Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma 264Osteosarcoma 80Sarcoma, Ewing 50Neoplasms 43Melanoma 43Gastrointestinal Stromal Tumors 41Colorectal Neoplasms 39Breast Neoplasms 37Bone Neoplasms 36Rhabdomyosarcoma 35Neoplasm Metastasis 32Ovarian Neoplasms 31Neuroblastoma 30Pancreatic Neoplasms 29Stomach Neoplasms 27Dendritic Cell Sarcoma, Interdigitating 27Lung Neoplasms 26Liposarcoma 26Leiomyosarcoma 25Glioblastoma 23Uterine Cervical Neoplasms 22Sarcoma, Synovial 22Head and Neck Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Esophageal Neoplasms 21Sarcoma, Kaposi 18Lymphoma 18Carcinoma, Hepatocellular 18Urinary Bladder Neoplasms 17Prostatic Neoplasms 17

Interventions

elacestrant 1RAD1901 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenosarcoma of the uterus × Sarcoma × Clear all
NCT07467772 2026-05-22

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Dana-Farber Cancer Institute

Phase 2 Recruiting
30 enrolled
GynecologicSarcoma

Adenosarcoma of the uterus, Sarcoma, Endometrial Stromal, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡